These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9651928)

  • 1. Definition of T cell epitopes within the 19 kDa carboxylterminal fragment of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) and their role in immunity to malaria.
    Tian JH; Good MF; Hirunpetcharat C; Kumar S; Ling IT; Jackson D; Cooper J; Lukszo J; Coligan J; Ahlers J; Saul A; Berzofsky JA; Holder AA; Miller LH; Kaslow DC
    Parasite Immunol; 1998 Jun; 20(6):263-78. PubMed ID: 9651928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria.
    Wipasa J; Hirunpetcharat C; Mahakunkijcharoen Y; Xu H; Elliott S; Good MF
    J Immunol; 2002 Jul; 169(2):944-51. PubMed ID: 12097400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.
    Stanisic DI; Martin LB; Liu XQ; Jackson D; Cooper J; Good MF
    Infect Immun; 2003 Oct; 71(10):5700-13. PubMed ID: 14500491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
    Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
    Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
    Tian JH; Kumar S; Kaslow DC; Miller LH
    Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
    Matsumoto S; Yukitake H; Kanbara H; Yamada T
    J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
    Ahlborg N; Ling IT; Holder AA; Riley EM
    Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria.
    Chauhan VS; Chatterjee S; Johar PK
    Parasite Immunol; 1993 Apr; 15(4):239-42. PubMed ID: 7685076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.
    Wipasa J; Xu H; Makobongo M; Gatton M; Stowers A; Good MF
    Infect Immun; 2002 Nov; 70(11):6013-20. PubMed ID: 12379677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.
    Alaro JR; Lynch MM; Burns JM
    Vaccine; 2010 Oct; 28(42):6876-84. PubMed ID: 20709001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.
    Singh B; Cabrera-Mora M; Jiang J; Galinski M; Moreno A
    Vaccine; 2010 Mar; 28(14):2580-92. PubMed ID: 20097151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
    Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
    Rénia L; Ling IT; Marussig M; Miltgen F; Holder AA; Mazier D
    Infect Immun; 1997 Nov; 65(11):4419-23. PubMed ID: 9353014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
    Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC
    J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.
    Yoshida S; Nagumo H; Yokomine T; Araki H; Suzuki A; Matsuoka H
    PLoS One; 2010 Oct; 5(10):e13727. PubMed ID: 21060850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.
    Hirunpetcharat C; Vukovic P; Liu XQ; Kaslow DC; Miller LH; Good MF
    J Immunol; 1999 Jun; 162(12):7309-14. PubMed ID: 10358180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8.
    Alaro JR; Angov E; Lopez AM; Zhou H; Long CA; Burns JM
    Infect Immun; 2012 Jul; 80(7):2473-84. PubMed ID: 22585960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.